Leica HistoCore PEGASUS (PROCESSOR, TISSUE, AUTOMATED) — FDA record Z-0590-2024

Reported ongoing

Status as reported in the agency record. FDA warns that enforcement status may not track the current recall lifecycle; check the current official notice.

Source date Nov 20, 2023. Retrieved Oct 1, 2026. Last updated Oct 1, 2026.

Archive changed Oct 1, 2026. USDA FSIS records are unavailable; check FSIS directly. Source coverage and dates.

What the record says

Product
Leica HistoCore PEGASUS (PROCESSOR, TISSUE, AUTOMATED)
Reason
There is an issue regarding poorly processed and/or damaged biopsy tissue specimens on the HistoCore PEGASUS / HistoCore PEGASUS Plus resulting from an incorrect assignment of the carryover value set for created or edited protocols.
Classification
Class II
Recalling firm
LEICA BIOSYSTEMS NUSSLOCH GMBH
Quantity
98 devices
Agency-reported status
Ongoing
Source record identifier
Z-0590-2024

Open the official record

What the recall classes mean. Classification is an agency assessment, not individual medical advice.

Lot and product identifiers

Label fieldDetails supplied by the agency
Lot, code or applicabilityAll devices with serial number: G0061-G0701

Match all identifying details in the current notice. A brand name alone is not enough.

Distribution

US, Nationwide

States below are derived from the distribution text, including nationwide wording. They are not inferred from the firm's address.

Dates in the source

Report date
May 1, 2024
Recall initiation date
Nov 20, 2023
Center classification date
Dec 19, 2023

FDA company pages use the listing date; enforcement records use initiation dates; CPSC uses recall date; NHTSA uses report-received date. These dates are not interchangeable.

Related records